Indoco Remedies Limited (BOM:532612)
India
· Delayed Price · Currency is INR 232.15
-6.75 (-2.83%)
At close: Apr 25, 2025
Indoco Remedies Statistics
Total Valuation
Indoco Remedies has a market cap or net worth of INR 21.45 billion. The enterprise value is 29.37 billion.
| Market Cap | 21.45B |
| Enterprise Value | 29.37B |
Important Dates
The next estimated earnings date is Friday, May 16, 2025.
| Earnings Date | May 16, 2025 |
| Ex-Dividend Date | Sep 19, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -8.29% |
| Shares Change (QoQ) | -2.41% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 36.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.24 |
| PB Ratio | 1.97 |
| P/TBV Ratio | 2.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -275.48 |
| EV / Sales | 1.70 |
| EV / EBITDA | 28.17 |
| EV / EBIT | 76.18 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.77 |
| Debt / EBITDA | 8.01 |
| Debt / FCF | n/a |
| Interest Coverage | 0.65 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 1.38% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 2.87M |
| Profits Per Employee | -17,767 |
| Employee Count | 5,929 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.39% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -29.39% |
| 50-Day Moving Average | 236.51 |
| 200-Day Moving Average | 306.18 |
| Relative Strength Index (RSI) | 45.78 |
| Average Volume (20 Days) | 16,416 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Indoco Remedies had revenue of INR 17.24 billion and -106.60 million in losses. Loss per share was -1.25.
| Revenue | 17.24B |
| Gross Profit | 11.30B |
| Operating Income | 385.48M |
| Pretax Income | 41.29M |
| Net Income | -106.60M |
| EBITDA | 1.01B |
| EBIT | 385.48M |
| Loss Per Share | -1.25 |
Balance Sheet
The company has 417.30 million in cash and 8.34 billion in debt, giving a net cash position of -7.93 billion.
| Cash & Cash Equivalents | 417.30M |
| Total Debt | 8.34B |
| Net Cash | -7.93B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 10.89B |
| Book Value Per Share | 124.09 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 65.54%, with operating and profit margins of 2.24% and -0.62%.
| Gross Margin | 65.54% |
| Operating Margin | 2.24% |
| Pretax Margin | 0.24% |
| Profit Margin | -0.62% |
| EBITDA Margin | 5.83% |
| EBIT Margin | 2.24% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 0.61%.
| Dividend Per Share | 1.50 |
| Dividend Yield | 0.61% |
| Dividend Growth (YoY) | -33.33% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 8.29% |
| Shareholder Yield | 8.90% |
| Earnings Yield | -0.50% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on May 17, 2012. It was a forward split with a ratio of 7.5.
| Last Split Date | May 17, 2012 |
| Split Type | Forward |
| Split Ratio | 7.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |